# MEDROXYPROGESTERONE ACETATE
> **ANDA210335** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-01-25
## Drug
- **FDA Application Number:** ANDA210335
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEDROXYPROGESTERONE ACETATE
- **Generic name:** Medroxyprogesterone Acetate
- **Active ingredients:** MEDROXYPROGESTERONE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** CIPLA
- **First approval:** 2019-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210335)
---
*AI Analytics · CC0 1.0*